Advanced Search

Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 June;59(2)

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUETHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging

A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413

Frequency: Quarterly

ISSN 1824-4785

Online ISSN 1827-1936

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 June;59(2)

25 YEARS OF IMMUNOSCINTIGRAPHY AND THERAPY WITH IRIST 

     EDITORIAL

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 June;59(2):137-9

The long history of the International Research Group in Immuno-Scintigraphy and Therapy (IRIST)

Chatal J. F., Perkins A. C., Baum R. P., Bischof Delaloye A., Prior J., Signore A.


     REVIEWS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 June;59(2):140-51

The imaging of neuroendocrine tumors using single photon emission computed tomography/computed tomography

Upadhyay B., Lu S.-J., Navalkissoor S., Gnanasegaran G., Buscombe J.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 June;59(2):152-60

GLP-1 and exendin-4 for imaging endocrine pancreas. A review. Labelled glucagon-like peptide-1 analogues: past, present and future

Hubalewska-Dydejczyk A., Sowa-Staszczak A., Tomaszuk M., Stefańska A.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 June;59(2):161-7

Which radionuclide, carrier molecule and clinical indication for alpha-immunotherapy?

Guerard F., Barbet J., Chatal J.-F., Kraeber-Bodere F., Cherel M., Haddad F.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 June;59(2):168-83

New approaches for imaging and therapy of solid cancer

Sollini M., Boni R., Traino A. C., Lazzeri E., Pasqualetti F., Modeo L., Mariani G., Petrini M., Erba P. A.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 June;59(2):184-96

New approaches to image thyroid cancer cells and microenvironment

Galli F., Iodice V., Lauri C., Signore A.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 June;59(2):197-213

SPECT radiopharmaceuticals for imaging chronic inflammatory diseases in the last decade

Anzola L. K., Galli F., Dierckx R. A.


     ORIGINAL ARTICLES

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 June;59(2):214-9

Using PET-CT in the restaging of primitive mediastinal B-cell lymphoma (PMBCL) after chemotherapy: which criteria should we use?

Giunta F., Zotta M., Menga M., Balma M., Bellò M., Passera R., Filippi A. R., Chiappella A., Ladetto M., Ricardi U., Vitolo U., Bisi G.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 June;59(2):220-7

18F-FDG SPECT/CT in the diagnosis of differentiated thyroid carcinoma with elevated thyroglobulin and negative iodine-131 scans

Ma C., Wang X., Shao M., Zhao L., Jiawei X., Wu Z., Wang H.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 June;59(2):228-37

Targeted ED-B fibronectin SPECT in vivo imaging in experimental atherosclerosis

Dietrich T., Berndorff D., Heinrich T., Hucko T., Stepina E., Hauff P., Dinkelborg L. M., Atrott K., Giovannoni L., Neri D., Fleck E., Graf K., Menssen H. D.


top of page